Abstract
The purpose of the study is to analyze the effectiveness and side effects of botulinum toxin using four different treatment site applications to determine the most successful treatment regime with the least side effects. In a prospective trial, 92 patients (50 blepharospasm and 42 hemifacial spasm) were assigned randomly to 1 of 4 different treatment groups (standard [S], brow [B], inner orbital [IO], or outer orbital [OO]). Each treatment group had a different pattern of injection sites in the orbicularis. A total of 285 treatments were given, and the mean follow-up time was 16.4 months. In the blepharospasm group, patients assigned to the standard group had a significantly longer duration of effect than for those in the brow, inner orbital, and outer orbital groups (8.1 weeks compared with 4.5, 4.2, and 3.1 weeks, respectively; P < 0.001). In the hemifacial spasm group, patients in the outer orbital group had significantly shorter duration of effect than those in standard, brow, or inner orbital group (7.2 weeks compared with 12.6, 12.8 and 10.4 weeks, respectively; P < 0.001). The four major complications of botulinum toxin treatment were epiphora, ocular irritation, ptosis, and diplopia. The inner orbital treatment produced...Continue Reading
References
Dec 1, 1988·Archives of Otolaryngology--head & Neck Surgery·A W BiglanR A Bowers
Aug 1, 1987·Ophthalmology·J A MaurielloE J Haupt
Jul 1, 1986·Ophthalmology·B R Frueh, D C Musch
Nov 1, 1994·Australian and New Zealand Journal of Ophthalmology·J Price, J O'Day
Citations
Jan 12, 2011·Journal of Neural Transmission·Bettina WabbelsPeter Roggenkämper
Mar 20, 2002·Current Neurology and Neuroscience Reports·R Tintner, J Jankovic
May 20, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Timothy Corcoran Flynn, Robert E Clark
Nov 23, 2006·Ophthalmic Plastic and Reconstructive Surgery·Mirwat S SamiLarry H Hollier
Feb 18, 2016·Journal of Ophthalmology·Hui YangLin Lu
Mar 8, 2008·Parkinsonism & Related Disorders·Daniel TruongUNKNOWN Dysport Benign Essential Blepharospasm Study Group
Jan 19, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R BhidayasiriD D Truong
Feb 1, 2005·European Journal of Pharmacology·Shinji YonedaHideaki Hara
Jan 7, 2005·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Wagner Henriques CastroRicardo Santiago Gomez
May 26, 2004·Clinics in Dermatology·Jean Carruthers, Alastair Carruthers
Jun 21, 2006·Expert Review of Neurotherapeutics·Roongroj Bhidayasiri, Daniel Tarsy
Oct 29, 2003·Physical Medicine and Rehabilitation Clinics of North America·Glenn T Clark
Jan 19, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K FreiD Dressler
Jun 24, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Mine Hayriye SorgunMuhittin Cenk Akbostanci
Sep 6, 2014·Ophthalmic Plastic and Reconstructive Surgery·Tiffany L KentJohn B Holds
Apr 30, 2004·Muscle & Nerve·Cynthia L Comella, Seth L Pullman
Jan 28, 2005·The Cochrane Database of Systematic Reviews·J CostaC Sampaio
Aug 18, 1999·Arquivos de neuro-psiquiatria·H FriedhoferM C Ferreira
Jan 28, 2005·The Cochrane Database of Systematic Reviews·J CostaC Sampaio
Nov 20, 2020·The Cochrane Database of Systematic Reviews·Gonçalo S DuarteJoão Costa
Nov 20, 2020·The Cochrane Database of Systematic Reviews·Gonçalo S DuarteJoão Costa
Dec 7, 2020·Experimental Eye Research·José Álvaro Pereira Gomes, José Arthur Pinto Milhomens Filho
Jul 14, 2020·Revue neurologique·Y A RayessM W Nasr
Jan 13, 2021·Toxins·Charenya Anandan, Joseph Jankovic
Jan 24, 2002·Neurology·S EisenschenkR Gonzalez